Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Mespere Lifesciences Inc.
With
Wayne State University
The ability to non-invasively, accurately, and continuously measure CVP to assess the preload status of ED patients could lead to its inclusion into existing protocols (similar to EGDT), or the development of novel protocols for the treatment of patients with fluid sensitive conditions. The majority of other non-invasive measures of preload, such as ultrasound of the inferior vena cava or the passive leg raise technique are not continuous measures and require some type of effort or skill on the part of the clinician. Continuous methods of assessing preload include CVP measurement through a central venous catheter, esophageal Doppler monitoring, and pulse contour analysis via arterial catheter monitoring, all of which involve invasive procedures.
The Venus CVP device is non-invasive and has continuous monitoring capabilities. The data acquired from this project will allow us to determine whether emergency physicians will, in practice, utilize the information provided by a non-invasive CVP monitoring device to assist in the management of their patients with severe sepsis or acute HF.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 18 years old or greater
English speaking
Clinical diagnosis of: 1) Severe Sepsis, or 2) Acute Heart Failure
You may not be if
Traumatic injuries
Active bleeding
Pregnancy
Prisoners
Central venous catheter placement in the internal jugular or subclavian veins
Bilateral external jugular vein catheterizations
Concurrent enrollment into an interventional clinical trial that may affect subject treatment